JACINTO FERRER: Open Payments
NPI 1720636707 · NORTH BERGEN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$680 in 27 payments from 13 companies in 2025. Trend: 2023 $288 · 2024 $145 · 2025 $680
Food & beverage: $680
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $181 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $153 |
| Xeris Pharmaceuticals, Inc. | 5 | $77 |
| ABBVIE INC. | 3 | $54 |
| Corcept Therapeutics | 3 | $41 |
| Lilly USA, LLC | 2 | $33 |
| Insulet Corporation | 1 | $28 |
| Tandem Diabetes Care, Inc. | 1 | $27 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Amgen Inc. | 1 | $19 |
Products named: JARDIANCE, Ozempic, GVOKE HYPOPEN, SYNTHROID, Korlym, Wegovy, MOUNJARO, Omnipod.
Industry payments across NJ — which companies pay providers there.
